DONATE TODAY
May 29, 2019

Rebound of medication abortion in Texas following updated mifepristone label

In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label.
Share
Facebook
LinkedIn
X

Rebound of medication abortion in Texas following updated mifepristone label

https://doi.org/10.1016/j.contraception.2019.01.001

Details
Date
May 29, 2019
Category
Abortion Care
Journal
The journal Contraception
Authors
Sarah E. Baum, Kari White, Kristine Hopkins, Joseph E. Potter, Daniel Grossman
key findings
Citation
Related Publications

Post-Dobbs Realities: Ethical Imperatives for Data Transparency and Trust in Maternal Health Care

Policy Analysis

Restricting Access To Medication Abortion Will Not Help Survivors Of Intimate Partner Violence

Abortion Care, Texas

Texas’ Abortion Ban Conflicts With Person-Centered Health Care: Experiences of Texans With Medically Complex Pregnancies

Abortion Care, Journal Articles, Policy Analysis, Texas

Changes in Facility-Based Abortion Care Among Texas Resident Minors and Young Adults After a 2021 Abortion Ban: September 2020-May 2022

Abortion Care, Journal Articles, Policy Analysis, Texas